UCB: Full Year 2007 Financial Results
Brussels (BELGIUM), 29 February 2008 at 7:00 AM CET - UCB today announces its consolidated full year 2007 financial results.
Roch Doliveux, CEO of UCB, comments: "2007 was an important year for UCB - especially with two new product launches in the USA, four regulatory filings in the USA and the EU. We achieved an impressive amount of R&D milestones, although we did not meet all our R&D goals. I am particularly proud that more and more patients with severe diseases, especially with epilepsy and movement disorders, benefit from UCB's medicines. I am also pleased by the underlying positive financial performance, which is in line with previous years' all time high performance and supported by our successful integration."
Stay up-to-date on the latest news and information from UCB